Immobilization of organophosphate hydrolase on an amyloid fibril nanoscaffold: Towards bioremediation and chemical detoxification

Biotechnology Progress

Volumn 27, Issue 2, 2011, Pages 360-367

  Raynes, Jared K ^a   Pearce, F Grant ^a   Meade, Susie J ^b   Gerrard, Juliet A ^a  

^a UNIVERSITY OF CANTERBURY   (New Zealand)

^b THE NEW ZEALAND INSTITUTE FOR PLANT AND FOOD RESEARCH LIMITED   (New Zealand)

Author keywords

Amyloid fibril; Bioremediation; Chemical detoxification; Immobilization; Organophosphate hydrolase

Indexed keywords

AMYLOID FIBRIL; CROSS-LINKING REAGENTS; CRYSTALLIN; DETOXIFICATION ENZYMES; FREE ENZYME; GLUTARALDEHYDES; IMMOBILIZATION; INDUSTRIAL SCALE; INSULIN AMYLOID FIBRILS; NANOSCAFFOLDS; ORGANOPHOSPHATE HYDROLASE; PARAOXON; RELATIVE TEMPERATURES; TEMPERATURE STABILITY;

ALDEHYDES; BIODEGRADATION; BIOREMEDIATION; BIOTECHNOLOGY; CENTRIFUGATION; CHEMICAL STABILITY; CROSSLINKING; DETOXIFICATION; ENZYME ACTIVITY; ENZYMES; GLYCOPROTEINS; HYDROLASES; INSULIN; POLLUTION; REUSABILITY; TRANSMISSION ELECTRON MICROSCOPY;

ENZYME IMMOBILIZATION;

AMYLOID; CHOLINESTERASE INHIBITOR; IMMOBILIZED ENZYME; INSECTICIDE; PARAOXON; PHOSPHATASE; PHOSPHORYLPHOSPHATASE;

ARTICLE; BIOREMEDIATION; ENZYME STABILITY; HEAT; INDUSTRIAL WASTE; METABOLISM; NANOTECHNOLOGY;

AMYLOID; BIODEGRADATION, ENVIRONMENTAL; CHOLINESTERASE INHIBITORS; ENZYME STABILITY; ENZYMES, IMMOBILIZED; HOT TEMPERATURE; INDUSTRIAL WASTE; INSECTICIDES; NANOTECHNOLOGY; PARAOXON; PHOSPHORIC MONOESTER HYDROLASES;

EID: 79953844432     PISSN: 87567938     EISSN: 15206033     Source Type: Journal    
DOI: 10.1002/btpr.518     Document Type: Article

References (62)

1. Dumas D, Caldwell SR, Wild J, Raushel FM. Purification and properties of the phosphotriesterase from Pseudomonas diminuta. J Biol Chem. 1989; 264: 19659-19665.
2. Hill C, Li W, Thoden J, Holden H, Raushel FM. Enhanced degradation of chemical warfare agents through molecular engineering of the phosphotriesterase active site. J Am Chem Soc. 2003; 125: 8990-8991.
3. Mulchandani A, Mulchandani P, Chen W. Enzyme biosensor for determination of organophosphates. Field Anal Chem Technol. 1998; 2: 363-369.
4. Ghanem E, Raushel FM. Detoxification of organophosphate nerve agents by bacterial phosphotriesterase. Toxicol Appl Pharmacol. 2005; 207(2, Suppl 1): 459-470.
5. Eddleston M. Patterns and problems of deliberate self-poisoning in the developing world. QJM. 2000; 93: 715-731.
6. De Silva H, Samarawickrema N, Wickremasinghe A. Toxicity due to organophosphorus compounds: what about chronic exposure? Trans R Soc Trop Med Hyg. 2006; 100: 803-806.
7. Rebmann T, Clements BW, Bailey JA, Evans RG. Organophosphate antidote auto-injectors vs. traditional administration: a time motion study. J Emerg Med. 2009; 37: 139-143.
8. Yair S, Ofer B, Arik E, Shai S, Yossi R, Tzvika D, Amir K. Organophosphate degrading microorganisms and enzymes as biocatalysts in environmental and personal decontamination applications. Crit Rev Biotechnol. 2008; 28: 265-275.
9. Mulchandani A, Mulchandani P, Kaneva I, Chen W. Biosensor for direct determination of organophosphate nerve agents using recombinant Escherichia coli with surface-expressed organophosphorus hydrolase. 1. Potentiometric microbial electrode. Anal Chem. 1998; 70: 4140-4145.
10. Krajewska B. Application of chitin-and chitosan-based materials for enzyme immobilizations: a review. Enzyme Microb Technol. 2004; 35: 126-139.
11. Sheldon RA. Enzyme immobilization: the quest for optimum performance. Adv Synth Catal. 2007; 349: 1289-1307.
12. Balcão VM, Paiva AL, Xavier Malcata F. Bioreactors with immobilized lipases: state of the art. Enzyme Microbial Technol. 1996; 18: 392-416.
13. D'Souza S. Immobilized enzymes in bioprocess. Curr Sci. 1999; 77: 69-79.
14. Liang JF, Li YT, Yang VC. Biomedical application of immobilized enzymes. J Pharm Sci. 2000; 89: 979-990.
15. Roodveldt C, Tawfik D. Directed evolution of phosphotriesterase from Pseudomonas diminuta for heterologous expression in Escherichia coli results in stabilization of the metal-free state. Protein Eng Des Sel. 2005; 18: 51-58.
16. Havens P, Rase H. Reusable immobilized enzyme/polyurethane sponge for removal and detoxification of localized organophosphate pesticide spills. Ind Eng Chem Res. 1993; 32: 2254-2258.
17. Chen W, Mulchandani A. The use of live biocatalysts for pesticide detoxification. Trends Biotechnol. 1998; 16: 71-76.
18. Di Sioudi B, Miller C, Lai K, Grimsley J, Wild J. Rational design of organophosphorus hydrolase for altered substrate specificities. Chem Biol Interact. 1999; 119-120: 211-223.
19. Grimsley JK, Calamini B, Wild JR, Mesecar AD. Structural and mutational studies of organophosphorus hydrolase reveal a cryptic and functional allosteric-binding site. Arch Biochem Biophys. 2005; 442: 169-179.
20. Fágáin CÓ. Understanding and increasing protein stability. BBA-Protein Struct M. 1995; 1252: 1-14.
21. Dumas D, Raushel FM. Chemical and kinetic evidence for an essential histidine in the phosphotriesterase from Pseudomonas diminuta. J Biol Chem. 1990; 265: 21498-21503.
22. Caldwell SR, Newcomb JR, Schlecht KA, Raushel FM. Limits of diffusion in the hydrolysis of substrates by the phosphotriesterase from Pseudomonas diminuta. Biochemistry. 1991; 30: 7438-7444.
23. LeJeune K, Mesiano A, Bower S, Grimsley J, Wild J, Russell A. Dramatically stabilized phosphotriesterase-polymers for nerve agent degradation. Biotechnol Bioeng. 1997; 54: 105-114.
24. Gill I, Ballesteros A. Degradation of organophosphorous nerve agents by enzyme-polymer nanocomposites: efficient biocatalytic materials for personal protection and large-scale detoxification. Biotechnol Bioeng. 2000; 70: 400-410.
25. Caldwell SR, Raushel FM. Detoxification of organophosphate pesticides using an immobilized phosphotriesterase from Pseudomonas diminuta. Biotechnol Bioeng. 1991; 37: 103-109.
26. Andreopoulos FM, Roberts MJ, Bentley MD, Harris JM, Beckman EJ, Russell AJ. Photoimmobilization of organophosphorus hydrolase within a PEG-based hydrogel. Biotechnol Bioeng. 1999; 65: 579-588.
27. Chiti F, Dobson CM. Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem. 2006; 75: 333-366.
28. Harrison R, Sharpe P, Singh Y, Fairlie D. Amyloid peptides and proteins in review. Rev Physiol Biochem Pharmacol. 2007; 159: 1-77.
29. Fowler DM, Koulov AV, Balch WE, Kelly JW. Functional amyloid-from bacteria to humans. Trends Biochem Sci. 2007; 32: 217-224.
30. Jordal P, Dueholm M, Larsen P, Petersen S, Enghild J, Christiansen G, Højrup P, Nielsen P, Otzen D. Widespread abundance of functional bacterial amyloid in mycolata and other gram-positive bacteria. Appl Environ Microbiol. 2009; 75: 4101-4110.
31. Shewmaker F, McGlinchey R, Thurber K, McPhie P, Dyda F, Tycko R, Wickner R. The functional curli amyloid is not based on in-register parallel β-sheet structure. J Biol Chem. 2009; 284: 25065-25076.
32. Gras SL, Tickler AK, Squires AM, Devlin GL, Horton MA, Dobson CM, MacPhee CE. Functionalised amyloid fibrils for roles in cell adhesion. Biomaterials. 2008; 29: 1553-1562.
33. Guglielmi F, Monti D, Arciello A, Torrassa S, Cozzolino F, Pucci P, Relini A, Piccoli R. Enzymatically active fibrils generated by the self-assembly of the ApoA-I fibrillogenic domain functionalized with a catalytic moiety. Biomaterials. 2009; 30: 829-835.
34. Garvey M, Gras SL, Meehan S, Meade SJ, Carver JA, Gerrard JA. Protein nanofibres of defined morphology prepared from mixtures of crude crystallins. Int J Nanotechnol. 2009; 6: 258-273.
35. Reaction mixed to hoki quota increase-SeafoodSource.com. Available at: [Accessed August 19, 2010].
36. Cherny I, Gazit E. Amyloids: Not only pathological agents but also ordered nanomaterials13. Angew Chem Int Edit. 2008; 47: 4062-4069.
37. Gras SL. Amyloid fibrils: from disease to design. New biomaterial applications for self-assembling cross-β fibrils. Aust J Chem. 2007; 60: 333-342.
38. Pilkington SM, Roberts SJ, Meade SJ, Gerrard JA. Amyloid fibrils as a nanoscaffold for enzyme immobilisation. Biotechnol Prog. 2009. Available at: [Accessed October 15, 2009].
39. Waterhouse SH, Gerrard JA. Amyloid fibrils in bionanotechnology. Aust J Chem. 2004; 57: 519-523.
40. Gras SL, Tickler AK, Squires AM, Devlin GL, Horton MA, Dobson CM, MacPhee CE. Functionalised amyloid fibrils for roles in cell adhesion. Biomaterials. 2008; 29: 1553-1562.
41. Scanlon S, Aggeli A. Self-assembling peptide nanotubes. Nano Today. 2008; 3: 22-30.
42. MacPhee, Dobson CM. Formation of mixed fibrils demonstrates the generic nature and potential utility of amyloid nanostructures. J Am Chem Soc. 2000; 122: 12707-12713.
43. Baldwin A, Bader R, Christodoulou J, MacPhee C, Dobson CM, Barker P. Cytochrome display on amyloid fibrils. J Am Chem Soc. 2006; 128: 2162-2163.
44. Ge J, Lu D, Liu Z, Liu Z. Recent advances in nanostructured biocatalysts. Biochem Eng J. 2009; 44: 53-59.
45. Ortiz C, Zhang D, Ribbe AE, Xie Y, Ben-Amotz D. Analysis of insulin amyloid fibrils by Raman spectroscopy. Biophys Chem. 2007; 128: 150-155.
46. Studier FW. Protein production by auto-induction in high-density shaking cultures. Protein Expr Purif. 2005; 41: 207-234.
47. McLoughlin S, Jackson C, Liu J, Ollis D. Increased expression of a bacterial phosphotriesterase in Escherichia coli through directed evolution. Protein Expr Purif. 2005; 41: 433-440.
48. Nielsen L, Khurana R, Coats A, Frokjaer S, Brange J, Vyas S, Uversky V, Fink A. Effect of environmental factors on the kinetics of insulin fibril formation: elucidation of the molecular mechanism. Biochemistry. 2001; 40: 6036-6046.
49. LeVine H III. Quantification of β-sheet amyloid fibril structures with thioflavin T. Methods Enzymol. 1999; 309: 274-284.
50. Whittingham JL, Scott DJ, Chance K, Wilson A, Finch J, Brange J, Guy Dodson G. Insulin at pH 2: structural analysis of the conditions promoting insulin fibre formation. J Mol Biol. 2002; 318: 479-490.
51. Shi D. Introduction to Biomaterials. Beijing, China: World Scientific Publishing Company; 2006.
52. Vanhooke J, Benning M, Raushel FM, Holden H. Three-dimensional structure of the zinc-containing phosphotriesterase with the bound substrate analog diethyl 4-methylbenzylphosphonate. Biochemistry. 1996; 35: 6020-6025.
53. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976; 72: 248-254.
54. Benning M, Kuo J, Raushel FM, Holden H. Three-dimensional structure of phosphotriesterase: an enzyme capable of detoxifying organophosphate nerve agents. Biochemistry. 1994; 33: 15001-15007.
55. Rochu D, Viguie N, Renault F, Crouzier D, Froment M, Masson P. Contribution of the active-site metal cation to the catalytic activity and to the conformational stability of phosphotriesterase: Temperature- and pH-dependence. Biochem J. 2004; 380: 627-633.
56. Migneault I, Dartiguenave C, Bertrand M, Waldron K. Glutaraldehyde: behavior in aqueous solution, reaction with proteins, and application to enzyme crosslinking. BioTechniques. 2004; 37: 790-802.
57. Meade SJ, Miller AG, Gerrard JA. The role of dicarbonyl compounds in non-enzymatic crosslinking: a structure-activity study. Bioorg Med Chem. 2003; 11: 853-862.
58. Nilsson MR. Techniques to study amyloid fibril formation in vitro. Methods. 2004; 34: 151-160.
59. Mateo C, Palomo JM, Fernandez-Lorente G, Guisan JM, Fernandez-Lafuente R. Improvement of enzyme activity, stability and selectivity via immobilization techniques. Enzyme Microbial Technol. 2007; 40: 1451-1463.
60. Fernandez-Lafuente R. Stabilization of multimeric enzymes: strategies to prevent subunit dissociation. Enzyme Microbial Technol. 2009; 45: 405-418.
61. Iyer P, Ananthanarayan L. Enzyme stability and stabilization-aqueous and non-aqueous environment. Process Biochem. 2008; 43: 1019-1032.
62. Holland-Nell K, Beck-Sickinger AG. Specifically immobilised aldo/keto reductase AKR1A1 shows a dramatic increase in activity relative to the randomly immobilised enzyme. ChemBioChem. 2007; 8: 1071-1076.